Core Alternative Capital’s Idexx Laboratories IDXX Stock Holding History

Core Alternative Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	-$1.92K	–	278
2025 Q3	$1.92K	Hold	3	–	–	﹤0.01%	249
2025 Q2	$1.61K	Hold	3	–	–	﹤0.01%	253
2025 Q1	$1.26K	Hold	3	–	–	﹤0.01%	270
2024 Q4	$1.24K	Hold	3	–	–	﹤0.01%	294
2024 Q3	$1.52K	Hold	3	–	–	﹤0.01%	283
2024 Q2	$1.46K	Hold	3	–	–	﹤0.01%	279
2024 Q1	$1.62K	Sell	3 -20	-87%	-$10.9K	﹤0.01%	267
2023 Q4	$12.8K	Sell	23 -1	-4%	-$469	﹤0.01%	278
2023 Q3	$10.5K	Hold	24	–	–	﹤0.01%	319
2023 Q2	$12.1K	Buy	24 +1	+4%	+$479	﹤0.01%	292
2023 Q1	$11.5K	Buy	23 +3	+15%	+$1.44K	﹤0.01%	301
2022 Q4	$8.16K	Hold	20	–	–	﹤0.01%	313
2022 Q3	$7K	Hold	20	–	–	﹤0.01%	329
2022 Q2	$7K	Buy	20 +7	+54%	+$2.85K	﹤0.01%	332
2022 Q1	$7K	Buy	13 +10	+333%	+$5.26K	﹤0.01%	307
2021 Q4	$2K	Buy	+3	New	+$1.88K	﹤0.01%	305

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Core Alternative Capital's IDXX Position: Q4 2025 in Review

Core Alternative Capital sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 3 shares — an estimated $1.92K sold.

Core Alternative Capital first reported a position in IDXX in Q4 2021 and held it in 16 quarters. The position peaked at $12.8K in Q4 2023. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Core Alternative Capital reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Core Alternative Capital sold 3 Idexx Laboratories shares in Q4 2025, an estimated $1.92K.
Core Alternative Capital first reported a position in Idexx Laboratories in Q4 2021 and held it in 16 quarters.
Core Alternative Capital's Idexx Laboratories position peaked at $12.8K in Q4 2023.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.